“My wife and daughters cried, hid my car keys to stop me from going to the hospital for the vaccine trials.”
Santosh Krishna More, 50, CSR Consultant, Pune
Santosh Krishna More is among the first 10 Indians to get two doses for Phase II clinical trials of the Oxford University-AstraZeneca vaccine, Covishield. The 50-year-old CSR consultant got the first shot on August 26 in Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, and the second on September 29—almost a month apart. But he is unaware what the vials contained as it is not disclosed during clinical trials whether a vaccine or a placebo was administered. “They will after six months,” More says, adding that each volunteer has signed a contract with the Serum Institute of India, licensed to conduct the Covishield...
